Gruss HJ - Search Results

1

Differential CD95 expression and function in T and B lineage acute lymphoblastic leukemia cells.

Karawajew L, Wuchter C, Ruppert V, Drexler H, Gruss HJ, Dörken B, Ludwig WD. Karawajew L, et al. Among authors: gruss hj. Leukemia. 1997 Aug;11(8):1245-52. doi: 10.1038/sj.leu.2400746. Leukemia. 1997. PMID: 9264377

2

Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-alpha through posttranscriptional mRNA stabilization by a labile protein.

Brach MA, Bühring HJ, Gruss HJ, Ashman LK, Ludwig WD, Mertelsmann RH, Herrmann F. Brach MA, et al. Among authors: gruss hj. Blood. 1992 Sep 1;80(5):1224-30. Blood. 1992. Retraction in: Blood. 1999 May 15;93(10):3573.. PMID: 1381241 Free article. Retracted.

3

Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.

Gruss HJ, DaSilva N, Hu ZB, Uphoff CC, Goodwin RG, Drexler HG. Gruss HJ, et al. Leukemia. 1994 Dec;8(12):2083-94. Leukemia. 1994. PMID: 7528856

4

Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines.

Meierhoff G, Dehmel U, Gruss HJ, Rosnet O, Birnbaum D, Quentmeier H, Dirks W, Drexler HG. Meierhoff G, et al. Among authors: gruss hj. Leukemia. 1995 Aug;9(8):1368-72. Leukemia. 1995. PMID: 7643626

5

Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells.

Schumann RR, Nakarai T, Gruss HJ, Brach MA, von Arnim U, Kirschning C, Karawajew L, Ludwig WD, Renauld JC, Ritz J, Herrmann F. Schumann RR, et al. Among authors: gruss hj. Blood. 1996 Mar 15;87(6):2419-27. Blood. 1996. PMID: 8630406 Free article.

6

Synergy of interleukin 3 and tumor necrosis factor alpha in stimulating clonal growth of acute myelogenous leukemia blasts is the result of induction of secondary hematopoietic cytokines by tumor necrosis factor alpha.

Brach MA, Gruss HJ, Asano Y, de Vos S, Ludwig WD, Mertelsmann R, Herrmann F. Brach MA, et al. Among authors: gruss hj. Cancer Res. 1992 Apr 15;52(8):2197-201. Cancer Res. 1992. PMID: 1373106

7

Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product.

de Vos S, Brach MA, Asano Y, Ludwig WD, Bettelheim P, Gruss HJ, Herrmann F. de Vos S, et al. Among authors: gruss hj. Cancer Res. 1993 Aug 1;53(15):3638-42. Cancer Res. 1993. PMID: 7687925

8

Hodgkin's disease: a cytokine-producing tumor--a review.

Gruss HJ, Herrmann F, Drexler HG. Gruss HJ, et al. Crit Rev Oncog. 1994;5(5):473-538. doi: 10.1615/critrevoncog.v5.i5.30. Crit Rev Oncog. 1994. PMID: 8519809 Review.

9

Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells.

Gruss HJ, Brach MA, Drexler HG, Bross KJ, Herrmann F. Gruss HJ, et al. Cancer Res. 1992 Feb 15;52(4):1026-31. Cancer Res. 1992. PMID: 1737332

10

Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells.

Gruss HJ, Brach MA, Drexler HG, Bonifer R, Mertelsmann RH, Herrmann F. Gruss HJ, et al. Cancer Res. 1992 Jun 15;52(12):3353-60. Cancer Res. 1992. PMID: 1596893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters